Imigran Mite

Sumatriptan, the active ingredient in Imigran Mite, is a Triptan presented as a nasal spray for nasal use. It treats acute migraine attacks in adults.

GNH USA supplies Imigran Mite as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imigran Mite (sumatriptan) is a Triptan indicated for the acute management of migraine and related headache disorders. - Migraine: provides rapid relief of headache pain, photophobia, phonophobia and nausea associated with an acute migraine attack. - Cluster headache: may abort an acute cluster headache episode when administered early. - Acute trigeminal autonomic cephalalgia: can reduce pain intensity in selected patients with short‑lasting attacks.

Common Side Effects: - Taste disturbance: altered or unpleasant taste after administration. - Nasal irritation: burning, stinging or discomfort in the nasal passages. - Dizziness: transient light‑headedness or vertigo. - Fatigue: feeling unusually tired or weak. - Nausea: mild stomach upset or queasiness. - Dry mouth: reduced salivation after use.

Serious or Rare Side Effects: - Chest discomfort or tightness: possible cardiac ischemia. - Coronary vasospasm: constriction of heart vessels leading to angina. - Severe hypertension: sudden increase in blood pressure. - Serotonin syndrome: life‑threatening condition when combined with other serotonergic agents. - Allergic reaction: rash, swelling, or anaphylaxis. - Severe hypotension: abrupt drop in blood pressure.

Imigran Mite should be used with caution in patients with specific medical conditions and in conjunction with certain therapies. - Cardiovascular assessment: evaluate history of coronary artery disease, angina or stroke before use. - Avoid MAO‑inhibitors: do not co‑administer with monoamine oxidase inhibitors or within 14 days of discontinuation. - Hypertension monitoring: do not use in uncontrolled high blood pressure. - Serotonin syndrome vigilance: watch for symptoms if patient is on SSRIs, SNRIs or other serotonergic drugs. - Hypersensitivity check: discontinue if allergic reaction occurs. - Store at room temperature: keep in the original package, protect from moisture and heat.

Sumatriptan may interact with several drug classes, requiring careful management. Major Interactions (Avoid): - MAO inhibitors: increased risk of serotonin syndrome. - Other triptans: additive vasoconstrictive effects. - Ergot alkaloids: heightened vasospasm risk. - SSRIs/SNRIs: potential for serotonin toxicity. - Linezolid: similar serotonergic activity.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance blood pressure lowering. - CYP3A4 inhibitors (e.g., ketoconazole): may raise sumatriptan plasma levels. - Oral contraceptives: possible increased migraine frequency. - NSAIDs: monitor for gastrointestinal irritation.